Revolutionary Study Reveals Promising Results for Knee Osteoarthritis Using iPS Cell-Derived Components A pioneering clinical study presents groundbreaking results, showing that 71.4% of knee osteoarthritis patients improved after iPS cell-derived treatment, marking a potential medical breakthrough.

Revolutionary Study Reveals Promising Results for Knee Osteoarthritis Using iPS Cell-Derived Components #Japan #iPS_Cells #Knee_Osteoarthritis #Kobe #iPEACE_Inc.

Legendary Japanese Baseball Player Masumi Kuwata Becomes iPS Bio Venture ICE's Sports Ambassador Masumi Kuwata, a legendary figure in baseball, has joined iPS bio-venture ICE as the Sports Ambassador, promoting well-being and health initiatives.

Legendary Japanese Baseball Player Masumi Kuwata Becomes iPS Bio Venture ICE's Sports Ambassador #Japan #Tokyo #iPS_Cells #Masumi_Kuwata #Sports_Ambassador

I Peace Expands Frontiers in Regenerative Medicine with NKT Cell-Derived iPS Cells I Peace, a leader in cell therapy, successfully generates human iPS cells from NKT cells, paving the way for innovations in regenerative medicine and cancer therapy.

I Peace Expands Frontiers in Regenerative Medicine with NKT Cell-Derived iPS Cells #United_States #Palo_Alto #iPS_Cells #I_Peace #NKT_Cells

Next-Generation Approach to Beauty and Healthcare Using iPS Cells and Bioelectricity A partnership between ICE and TROMATZ integrates iPS cell technology with bioelectricity for innovative applications in hair and skincare, changing the industry.

Next-Generation Approach to Beauty and Healthcare Using iPS Cells and Bioelectricity #Japan #Tokyo #iPS_Cells #TROMATZ #Bioelectricity

New Partnership Between ICE and Toda Kobayashi Clinic to Innovate Beauty Treatments with iPS Cell Technology The partnership aims to develop innovative beauty medical solutions using iPS cell culture supernatant, combining expertise from orthopedics and aesthetic medicine.

New Partnership Between ICE and Toda Kobayashi Clinic to Innovate Beauty Treatments with iPS Cell Technology #Japan #iPS_Cells #Saitama #Toda_Kobayashi #ICE_Corporation

Transforming Women's Health: ICE and Koga Women's Clinic Partnership for Longevity ICE collaborates with Koga Women's Clinic to promote iPS-based longevity healthcare for women. Discover new horizons in women's health in Fukuoka.

Transforming Women's Health: ICE and Koga Women's Clinic Partnership for Longevity #Japan #Fukuoka #iPS_Cells #Womens_Health #Longevity_Healthcare

Revolutionizing Hair Care: A New Partnership in iPS Technology Production ICE and Afresca have teamed up to develop cutting-edge hair care products utilizing iPS cell technology, redefining wellness and beauty.

Revolutionizing Hair Care: A New Partnership in iPS Technology Production #Japan #Tokyo #iPS_Cells #Hair_Care #Afresca

ICE Partners with M. Wellness Clinic: Pioneering Wellness Medicine Utilizing iPS Cell Technology The collaboration between ICE and M. Wellness Clinic marks a significant step towards advanced wellness medicine, integrating iPS cell technology with nutritional science for improved patient care.

ICE Partners with M. Wellness Clinic: Pioneering Wellness Medicine Utilizing iPS Cell Technology #Japan #Nagoya #iPS_Cells #Wellness_Medicine #M._Wellness_Clinic

Next-Generation Scalp Care Products from Dr.TOUHI to Debut at Hair Care Expo Dr.TOUHI CLINIC will unveil cutting-edge scalp serums at Hair Care Expo 2026, featuring research-backed ingredients for future hair care.

Next-Generation Scalp Care Products from Dr.TOUHI to Debut at Hair Care Expo #Japan #Tokyo #iPS_Cells #Hair_Care #Dr.TOUHI

Alfresa Partners with Kei Pharma on iPS Cell Therapy Supply Chain Development Alfresa Corporation has entered a basic agreement with Kei Pharma to collaborate on the iPS cell-derived regenerative medical product supply chain, enhancing healthcare delivery.

Alfresa Partners with Kei Pharma on iPS Cell Therapy Supply Chain Development #Tokyo #iPS_Cells #Alfresa #Kei_Pharma

Unveiling the Beauty of BIOLUXE Face Mask by Laips: A Revolutionary Product for Radiant Skin Discover the transformative power of the BIOLUXE Face Mask by Laips, enriched with iPS cell culture supernatant for hydrated, radiant skin.

Unveiling the Beauty of BIOLUXE Face Mask by Laips: A Revolutionary Product for Radiant Skin #Japan #Tokyo #iPS_Cells #BIOLUXE #Laips

Okayama University Successfully Transplants Cartilage Tissue from Human iPS Cells to Mini-Pig Model Researchers at Okayama University have successfully created diverse cartilage tissues from human iPS cells, leading to significant advancements in regeneration therapies for joint diseases.

Okayama University Successfully Transplants Cartilage Tissue from Human iPS Cells to Mini-Pig Model #Japan #iPS_Cells #Okayama #Okayama_University #Cartilage_Tissue

New Glycan Marker Development Enhances iPS Cell Quality Control for Regenerative Medicine A research team has successfully developed a glycan marker enabling the identification of off-target cells in iPS cell-derived neuron populations.

New Glycan Marker Development Enhances iPS Cell Quality Control for Regenerative Medicine #Japan #Tokyo #iPS_Cells #Glycan_Marker #Stem_Cell_Reports

First Patient Treated with Hybrid iPS Cell Therapy for Cardiomyopathy iHeart Japan has successfully conducted the first treatment using their IHJ-301 hybrid therapy derived from iPS cells, paving the way for advanced heart disease interventions.

First Patient Treated with Hybrid iPS Cell Therapy for Cardiomyopathy #Japan #Heart_Disease #Kyoto #iPS_Cells #IHJ-301

Vita Therapeutics and I Peace Forge Path for iPS-derived Cells in FSHD Treatment Vita Therapeutics and I Peace announce a groundbreaking collaboration to develop iPS-derived cells aimed at addressing FSHD using cutting-edge technology for cellular therapies.

Vita Therapeutics and I Peace Forge Path for iPS-derived Cells in FSHD Treatment #United_States #Palo_Alto #iPS_Cells #FSHD #Vita_Therapeutics

I Peace Revolutionizes iPSC Development with Low Immunoreaction Risk Products for Therapies I Peace Inc. has launched new GMP iPSCs derived from type O female blood, reducing immunoreaction risk and enhancing cell therapy potential.

I Peace Revolutionizes iPSC Development with Low Immunoreaction Risk Products for Therapies #United_States #Palo_Alto #iPS_Cells #GMP_Cells #I_Peace

I Peace Reaches Milestone with 100 Lines of GMP iPS Cells Manufacturing I Peace, a leading GMP cell CDMO, has successfully manufactured 100 lines of GMP-grade iPS cells, marking a significant milestone in regenerative medicine.

I Peace Reaches Milestone with 100 Lines of GMP iPS Cells Manufacturing #United_States #Palo_Alto #iPS_Cells #GMP #Koji_Tanabe